Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Millenson, Michael
One or more keywords matched the following items that are connected to Millenson, Michael
Item TypeName
Concept Lymphoma, B-Cell
Concept Lymphoma, T-Cell
Concept Lymphoma, Large-Cell, Anaplastic
Concept Lymphoma, B-Cell, Marginal Zone
Concept Lymphoma, Mantle-Cell
Concept Enteropathy-Associated T-Cell Lymphoma
Academic Article Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions.
Academic Article Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Academic Article High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database.
Academic Article Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial.
Academic Article Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
Academic Article Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
Academic Article Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Academic Article Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database.
Academic Article Pediatric nodal marginal zone lymphoma may develop in the adult population.
Academic Article Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.
Academic Article An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.
Academic Article Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.
Search Criteria
  • Lymphoma B Cell